Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12617001495314p
Ethics application status
Not yet submitted
Date submitted
10/09/2017
Date registered
23/10/2017
Date last updated
23/10/2017
Type of registration
Prospectively registered
Titles & IDs
Public title
Evaluating an online intervention for General Practitioners (GPs) to use delayed prescribing for acute respiratory infections in general practice
Query!
Scientific title
Evaluating an online intervention for General Practitioners to use delayed prescribing for acute respiratory infections in general practice
Query!
Secondary ID [1]
292844
0
Nil known
Query!
Universal Trial Number (UTN)
Not applicable
Query!
Trial acronym
The GP4DP Trial
Query!
Linked study record
Not applicable
Query!
Health condition
Health condition(s) or problem(s) studied:
Respiratory Tract Infections
304944
0
Query!
Condition category
Condition code
Infection
304270
304270
0
0
Query!
Other infectious diseases
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Brief name: The GP4DP Trial
Purpose: The online intervention aims to facilitate delayed prescribing so if doctors and patients decide antibiotics are necessary, delayed prescribing is the first option and that it is carried out appropriately. Delayed prescribing, also called 'wait-and-see' prescribing, is when a General Practitioner (GP) makes an antibiotic prescription available during the consultation but asks the patient to delay its use to see if symptoms will resolve first.
Procedures: GPs will be given access to the online intervention
Materials: The intervention is an online space where GPs can access information on how to do delayed prescribing (short video), evidence of success and resources to give to the patient to take home. Resources will include an information sheet for patients to take home explaining what infection they have, how long it usually lasts, how they can manage their symptoms and what to look for if it worsens.
Who provides the intervention: The intervention is online.
When and how much: After recruitment, GPs will be given access to the website. It can be accessed at any time including the consultation. No face-to-face training will be provided. It is intended the website can be used on an ongoing basis, however, the duration of the intervention for this study will be 3 months during the study. The researchers will also be examining the GPs prescribing during the same three months the year before.
Tailoring: The intervention is not planned to be tailored in anyway, although the participants may contact and ask the research team questions about delayed prescribing.
Fidelity: The online intervention will be piloted and feedback will used for amendments before trial.
Query!
Intervention code [1]
299090
0
Behaviour
Query!
Comparator / control treatment
‘Usual care’. GPs at the control practices will not receive access to the online intervention until completion of trial when it will be offered gratis.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
303330
0
Rate of antibiotic dispensing of the target antibiotics for each GP (number of consultations for which one of the target antibiotics was dispensed per year).
Target antibiotics are those routinely used for ARIs (amoxicillin, roxithromycin, amoxy-clav, cefaclor, and cephalexin).
Antibiotic dispensing data for the target antibiotics will be collected from the Pharmaceutical Benefits Scheme, by prescriber number. Medicare Benefits Scheme -recorded consultations will be collected by provider number.
Query!
Assessment method [1]
303330
0
Query!
Timepoint [1]
303330
0
Baseline: the same three months of the trial the previous year (June, July and Aug 2017) and, the three months during the trial (June, July and Aug 2018)
Query!
Secondary outcome [1]
338659
0
There is no secondary outcome
Query!
Assessment method [1]
338659
0
Query!
Timepoint [1]
338659
0
There is not secondary outcome timepoint.
Query!
Eligibility
Key inclusion criteria
General practitioners in Australia; practising GPs
Query!
Minimum age
25
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
Is not practicing as a GP currently;
Has participated in a research study aimed at reducing antibiotic prescribing in the last 2 years.
Query!
Study design
Purpose of the study
Educational / counselling / training
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Practice will be randomised using a block-permuted design. The randomisation sequence will be produced by the trial statistician who will have no role in recruiting practices or consenting GPs. She will also provide allocation concealment by keeping the randomisation lists secure and only randomising practices when completed consent forms are received. The researchers responsible for recruitment will contact the statistician to randomise a practice.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
The randomisation sequence will be produced using the computer generated random numbers by the trial statistician.
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Power calculation:
From the Cochrane review of ‘Delayed antibiotics for respiratory infections’ the reduction in antibiotics used by patients was a 61% absolute decrease (Delayed prescribing resulted in 32% of patients using antibiotics compared to 93% of patients in the immediate prescription group). As the 10 studies in the review were more complex than this one we propose a reduction in absolute prescribing by 20%. For the primary outcome measure of antibiotic dispensing, power calculations suggest a required sample size of 10 practices (5 intervention, 5 control, a total of about 50 GPs, assuming an average of 5 consenting GPs per practice). With 80% power, a significance level of 5% and an intra-class correlation coefficient for the effect of clustering of 0.05, we will require 10 practices (or about 50 GPs) to detect a relative reduction in the rate of prescribing.
Statistical analysis:
The analysis will use Poisson regression with the mean rate of dispensing over 3 months, for each GP as the outcome, adjusted for previous prescribing rate (12 months prior to randomised action and 3 months during the trial). Using multi-level model that accounts for nesting of monthly rates within GP, and GPs within practices. We will also collect the total number of MBS-recorded consultations for each GP for the same periods so that adjustment can be made based on the number of billed consultations for each GP. All practices will be included in the analysis, on the intent-to-treat basis, even if GPs did not use the intervention or discontinued use during the 3 months period.
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
1/03/2018
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
31/05/2018
Query!
Actual
Query!
Date of last data collection
Anticipated
31/08/2018
Query!
Actual
Query!
Sample size
Target
50
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
ACT,NSW,NT,QLD,SA,TAS,WA,VIC
Query!
Funding & Sponsors
Funding source category [1]
297477
0
University
Query!
Name [1]
297477
0
University of the Sunshine Coast
Query!
Address [1]
297477
0
Faculty of Science, Health, Education and Engineering
University of the Sunshine Coast
90 Sippy Downs Dr
Sippy Downs
QLD 4556
Query!
Country [1]
297477
0
Australia
Query!
Funding source category [2]
297479
0
University
Query!
Name [2]
297479
0
Bond University
Query!
Address [2]
297479
0
Faculty of Health Science and Medicine
Bond University
University Drive
Robina, QLD 4229
Query!
Country [2]
297479
0
Australia
Query!
Primary sponsor type
University
Query!
Name
University of the Sunshine Coast
Query!
Address
Faculty of Science, Health, Education and Engineering
University of the Sunshine Coast
90 Sippy Downs Dr
Sippy Downs
QLD 4556
Query!
Country
Australia
Query!
Secondary sponsor category [1]
296473
0
University
Query!
Name [1]
296473
0
Bond University
Query!
Address [1]
296473
0
Faculty of Health Science and Medicine
Bond University
University Drive
Robina, QLD 4229
Query!
Country [1]
296473
0
Australia
Query!
Ethics approval
Ethics application status
Not yet submitted
Query!
Ethics committee name [1]
298579
0
Human Research Ethics Committee of the University of the Sunshine Coast
Query!
Ethics committee address [1]
298579
0
Research Ethics Block B University of the Sunshine Coast 90 Sippy Downs Dr Sippy Downs QLD 4556
Query!
Ethics committee country [1]
298579
0
Australia
Query!
Date submitted for ethics approval [1]
298579
0
31/10/2017
Query!
Approval date [1]
298579
0
Query!
Ethics approval number [1]
298579
0
Query!
Summary
Brief summary
Antibiotics treat infections by killing bacteria. Antibiotic resistance occurs when an antibiotic has lost its ability to kill the bacteria; the bacteria has become resistant to the antibiotic and continues to multiply. One of the main reasons antibiotics lose their effectiveness is we take antibiotics when we don’t need them. Most antibiotics are prescribed for respiratory tract infections, in the community, that often get better without the need for medical intervention. There are many strategies to help doctors and patients to reduce antibiotic use in the community. One of these strategies is called ‘delayed prescribing’. Delayed prescribing, also called ‘wait-and-see prescribing’, is the process whereby a general practitioner (GP) makes available an antibiotic prescription during the consultation, but asks the patient to delay its use to see if symptoms will resolve first. This has been used in other countries very successfully but has never been trialed in Australia. The GP4DP trial wants to test if delayed prescribing can help reduce antibiotic use in community for people who present to their GP with respiratory tract infections. This trial will ask GPs not to prescribe antibiotics unnecessarily and if they do think it might be necessary, to ask the patient to wait and see if the illness will get better on its own before taking the antibiotic. Other studies have shown that most people do wait before taking the antibiotics, complications are extremely rare and the amount of people who present to the Emergency Department does not increase.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Attachments [1]
2040
2040
0
0
/AnzctrAttachments/373621(v10-09-2017-13-03-18)-Participation Information Sheet.docx
(Participant information/consent)
Query!
Query!
Attachments [2]
2041
2041
0
0
/AnzctrAttachments/373621(v10-09-2017-13-03-31)-Provider Consent form.doc
(Participant information/consent)
Query!
Query!
Attachments [3]
2042
2042
0
0
/AnzctrAttachments/373621(v10-09-2017-13-03-41)-AFP-Profesional-Sargent-Delayed antibiotic prescribing.pdf
(Publication)
Query!
Query!
Attachments [4]
2043
2043
0
0
/AnzctrAttachments/373621(v10-09-2017-13-03-52)-BMCFP Research-Using theory to explore delayed prescribing.pdf
(Publication)
Query!
Query!
Contacts
Principal investigator
Name
77542
0
Ms Lucy Sargent
Query!
Address
77542
0
Faculty of Science, Health, Education and Engineering
University of the Sunshine Coast
90 Sippy Downs Dr
Sippy Downs
QLD 4556
Query!
Country
77542
0
Australia
Query!
Phone
77542
0
+61 400 447335 (m)
Query!
Fax
77542
0
Query!
Email
77542
0
[email protected]
Query!
Contact person for public queries
Name
77543
0
Lucy Sargent
Query!
Address
77543
0
Faculty of Science, Health, Education and Engineering
University of the Sunshine Coast
90 Sippy Downs Dr
Sippy Downs
QLD 4556
Query!
Country
77543
0
Australia
Query!
Phone
77543
0
+61 7 5430 2823
Query!
Fax
77543
0
Query!
Email
77543
0
[email protected]
Query!
Contact person for scientific queries
Name
77544
0
Lucy Sargent
Query!
Address
77544
0
Faculty of Science, Health, Education and Engineering
University of the Sunshine Coast
90 Sippy Downs Dr
Sippy Downs
QLD 4556
Query!
Country
77544
0
Australia
Query!
Phone
77544
0
+61 400 447335
Query!
Fax
77544
0
Query!
Email
77544
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF